US Broker Ratings

Mesoblast Limited (MESO): Investor Outlook Highlights 60% Potential Upside

For investors with an eye on the biotechnology sector, Mesoblast Limited (NASDAQ: MESO) offers an intriguing opportunity. The Australian-based company is making waves with its regenerative medicine products, and the..

Progyny, Inc. (PGNY) Stock Report: 27.65% Potential Upside Captures Investor Attention

Progyny, Inc. (NASDAQ: PGNY) is gaining traction in the healthcare sector with its innovative approach to fertility and family-building benefits. As a leader in healthcare plans, Progyny offers a compelling..

Select Medical Holdings Corpora (SEM): Investor Outlook on a 36.81% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.57 billion, the..

Astrana Health Inc. (ASTH): Investor Outlook Highlights 66% Potential Upside

Astrana Health Inc. (ASTH), a healthcare management company headquartered in Alhambra, California, is attracting significant investor attention due to its robust growth potential and an impressive analyst consensus. As the..

Omnicell, Inc. (OMCL) Stock Analysis: Potential 39% Upside Amidst Solid Growth in Healthcare Solutions

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare sector, stands out not just for its innovative solutions in medication management and adherence but also for its promising investment..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: 52% Potential Upside Sparks Interest

Investors are increasingly turning their attention to Scholar Rock Holding Corporation (SRRK), as a staggering 52.24% potential upside is catching the eye of those looking for promising opportunities in the..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a 51% Upside Potential in the Innovative Genomics Sector

Twist Bioscience Corporation (NASDAQ: TWST), a key player in the rapidly evolving field of synthetic biology and genomics, presents an intriguing investment opportunity, particularly for those with an eye on..

Metsera, Inc. (MTSR) Stock Analysis: A Potential 32.51% Upside in the Booming Biotech Sector

Metsera, Inc. (NASDAQ: MTSR), a burgeoning name in the biotechnology sphere, is captivating investor attention with its groundbreaking approach to tackling obesity and related metabolic disorders. The New York-based clinical-stage..

SS Innovations International (SSII) Stock Analysis: A Closer Look at Its 121.80% Revenue Growth Amidst a Challenging Market

SS Innovations International, Inc. (SSII), a pioneering force in the surgical robotics sector, has garnered significant attention with its staggering 121.80% revenue growth. As a commercial-stage company based in Gurugram,..

Phreesia, Inc. (PHR) Stock Analysis: A 37% Potential Upside Amid Robust Revenue Growth

Phreesia, Inc. (NYSE: PHR) is making waves in the healthcare sector with its innovative SaaS-based software and payment platform, serving a diverse clientele across the United States and Canada. With..

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring an 87% Potential Upside with Revolutionary Biotech Developments

Immunocore Holdings plc (NASDAQ: IMCR), a pioneering entity in the biotechnology sector, is capturing investor attention with its promising pipeline in immunotherapy and a striking potential upside of 87.05% based..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Exploring an 85.73% Potential Upside for Investors

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is capturing investor attention with its remarkable potential upside of 85.73% based on the current stock price and the average analyst target. As a key..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring 65% Potential Upside in Healthcare Innovation

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a key player in the healthcare sector’s medical devices industry, has been making waves with its innovative diabetes management solutions. Based in San Diego,..

Centessa Pharmaceuticals (CNTA) Investor Outlook: Stunning 38.65% Potential Upside Fuels Optimism

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a promising player in the biotechnology sector, is capturing the attention of investors with its significant potential upside. Headquartered in Altrincham, United Kingdom, this clinical-stage..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A Biotech Gem with 148% Upside Potential

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a burgeoning biopharmaceutical company, stands out in the biotechnology sector with an impressive 148.34% potential upside, according to analyst ratings. As investors navigate the complex..

LivaNova PLC (LIVN) Stock Analysis: A Promising 17.9% Upside Potential in Medical Devices

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, specializes in medical devices designed to address neurological and cardiac conditions. Headquartered in London, this UK-based company is gaining..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Biotech Innovator with 107.59% Potential Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage biotech company, is drawing significant attention from investors, thanks to its robust pipeline of novel therapeutics targeting rare endocrine diseases and endocrine-related tumors...

Adaptive Biotechnologies (ADPT) Stock Analysis: Navigating Biotech with 36% Revenue Growth and Strong Buy Ratings

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $2.12 billion, this Seattle-based company is at the..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Look at Growth Opportunities with a Promising 7.67% Upside

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a leading player in the biotechnology sector, offers a unique proposition for investors focused on the healthcare space. The company, based in Foster City, California,..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 22.76% Potential Upside in the Medical Device Sector

Alphatec Holdings, Inc. (ATEC), a pioneering name in the medical device industry, is attracting investor attention with a notable potential upside of 22.76% based on its current trading price of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds